March 10, 2026 · Form 4 insider transaction
PAKOLA STEVE sold 5,124 shares of REGENXBIO Inc. at $10.35 per share, a transaction worth $53.0K. The trade was recorded as open-market sale under a pre-scheduled Rule 10b5-1 plan and disclosed on an SEC Form 4, filed 2 days after the transaction.
This transaction was effected pursuant to a Rule 10b5-1 trading plan.